FDA Peptide Update: Category 2 Removals Explained BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what PEPTIDES: THE 2026 FDA CRACKDOWN CONTROVERSYWhy this is MASSIVE SEO RIGHT NOW BPC 157 banned